Comment on

• Molecular signatures in acute myeloid leukemia.

  Mrózek K, Radmacher MD, Bloomfield CD, Marcucci G. Mrózek K, et al. Curr Opin Hematol. 2009 Mar;16(2):64-9. doi: 10.1097/MOH.0b013e3283257b42. Curr Opin Hematol. 2009. PMID: 19468266 Free PMC article. Review.
• Advancements in the molecular pathogenesis of myelodysplastic syndrome.

  Epling-Burnette PK, List AF. Epling-Burnette PK, et al. Curr Opin Hematol. 2009 Mar;16(2):70-6. doi: 10.1097/MOH.0b013e3283257ac7. Curr Opin Hematol. 2009. PMID: 19468267 Review.
• Optimal sequencing of treatments for patients with myelodysplastic syndromes.

  Itzykson R, Fenaux P. Itzykson R, et al. Curr Opin Hematol. 2009 Mar;16(2):77-83. doi: 10.1097/MOH.0b013e3283257a74. Curr Opin Hematol. 2009. PMID: 19468268 Review.
• Differentiation therapy of acute myeloid leukemia: past, present and future.

  Petrie K, Zelent A, Waxman S. Petrie K, et al. Curr Opin Hematol. 2009 Mar;16(2):84-91. doi: 10.1097/MOH.0b013e3283257aee. Curr Opin Hematol. 2009. PMID: 19468269 Review.
• Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?

  Dombret H, Preudhomme C, Boissel N. Dombret H, et al. Curr Opin Hematol. 2009 Mar;16(2):92-7. doi: 10.1097/MOH.0b013e3283257b18. Curr Opin Hematol. 2009. PMID: 19468270 Review.
• Impact of new prognostic markers in treatment decisions in acute myeloid leukemia.

  Schlenk RF, Döhner K. Schlenk RF, et al. Curr Opin Hematol. 2009 Mar;16(2):98-104. doi: 10.1097/MOH.0b013e3283257adb. Curr Opin Hematol. 2009. PMID: 19468271 Review.
• Novel postremission strategies in adults with acute myeloid leukemia.

  Lancet JE, Karp JE. Lancet JE, et al. Curr Opin Hematol. 2009 Mar;16(2):105-11. doi: 10.1097/MOH.0b013e3283257b04. Curr Opin Hematol. 2009. PMID: 19468272 Free PMC article. Review.
• Second hematopoietic stem cell transplantation in myeloid malignancies.

  Arfons LM, Tomblyn M, Rocha V, Lazarus HM. Arfons LM, et al. Curr Opin Hematol. 2009 Mar;16(2):112-23. doi: 10.1097/MOH.0b013e3283257a87. Curr Opin Hematol. 2009. PMID: 19468273 Free PMC article. Review.
• Umbilical cord blood transplantation for acute myeloid leukemia.

  Advani AS, Laughlin MJ. Advani AS, et al. Curr Opin Hematol. 2009 Mar;16(2):124-8. doi: 10.1097/MOH.0b013e3283257a60. Curr Opin Hematol. 2009. PMID: 19468274 Review.
• Novel strategies for patients with chronic myeloproliferative disorders.

  Barosi G, Rosti V. Barosi G, et al. Curr Opin Hematol. 2009 Mar;16(2):129-34. doi: 10.1097/MOH.0b013e3283257a9e. Curr Opin Hematol. 2009. PMID: 19468275 Free PMC article. Review.
• Appropriate sequencing of tyrosine kinase inhibitors in chronic myelogenous leukemia: when to change? A perspective in 2009.

  Mauro MJ. Mauro MJ. Curr Opin Hematol. 2009 Mar;16(2):135-9. doi: 10.1097/MOH.0b013e3283257b2b. Curr Opin Hematol. 2009. PMID: 19468276 Review.
• Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.

  Zang DY, Deeg HJ. Zang DY, et al. Curr Opin Hematol. 2009 Mar;16(2):140-6. doi: 10.1097/MOH.0b013e3283257ab2. Curr Opin Hematol. 2009. PMID: 19468277 Free PMC article. Review.